Fanapt Articles

Makers of Kynamro and Fanaptum to appeal negative CHMP opinions

17 December 2012

Mochida diabetes deal with Merck; Vanda links with Megapharm

14 December 2011

Emerging oral atypical antipsychotics will garner only limited uptake in schizophrenia market

25 February 2010

Shareholders sue Novartis and Alcon over merger deal; Novartis debuts Fanapt in USA

12 January 2010

Novartis buys back exclusive US/Canada rights from Vanda Pharmaceuticals for Fanapt in deal worth up to $465 million

13 October 2009

FDA shock turnaround sees Vanda's strategy pay off

8 May 2009

Showing 1-6 of 6 articles

Go to beginning

Previous

1

Next

Go to end